We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CATB market cap is 309.97M. The company's latest EPS is USD -2.0082 and P/E is -4.25.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -14.29M | -13.49M | -15.1M | -20.24M | -34.2M |
Net Income | -13.26M | -11.19M | -12.57M | -17.73M | -31.41M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -27.09M | -37.44M | -194.98M | -53.5M | -83.03M |
Net Income | -26.29M | -37.3M | -194.91M | -51.83M | -72.89M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 230.63M | 218.24M | 207.05M | 193.86M | 254.67M |
Total Liabilities | 9.42M | 6.88M | 6.65M | 9.38M | 11.55M |
Total Equity | 221.22M | 211.36M | 200.4M | 184.48M | 243.12M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 41.78M | 47.46M | 127.51M | 230.63M | 254.67M |
Total Liabilities | 6.06M | 6.79M | 5.2M | 9.42M | 11.55M |
Total Equity | 35.72M | 40.67M | 122.31M | 221.22M | 243.12M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -43.53M | -13.25M | -23.95M | -38.21M | -68.45M |
Investing | -167.13M | 194.99M | 137.07M | 137.07M | 135.05M |
Financing | 144.72M | 37k | 310k | 420k | 88.4M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -26.57M | -32.49M | -30.15M | -43.53M | -68.45M |
Investing | -4.08M | 6.3M | -12.56M | -167.13M | 135.05M |
Financing | 25.62M | 40.86M | 104.28M | 144.72M | 88.4M |
Market Cap | 309.97M |
Price to Earnings Ratio | -4.25 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.77 |
Price to Book Ratio | 1.27 |
Dividend Yield | - |
Shares Outstanding | 36.3M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.18 (2.09%) |
Company Name | Catabasis Pharmaceuticals Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.astriatx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions